[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 402 Engrossed in House (EH)]
<DOC>
H. Res. 402
In the House of Representatives, U. S.,
June 29, 2021.
Whereas in March 2021, a second wave of Coronavirus Disease 2019 (commonly
referred to as ``COVID-19'') infections began to surge in India,
overwhelming health care workers, hospitals, and crematoriums throughout
the country;
Whereas testing results indicate India is seeing more than 340,000 new daily
infections and upward of 4,000 deaths a day, though public health
experts believe case rates are higher;
Whereas cases have surged in neighboring countries such as Nepal and other
countries in the area remain highly vulnerable to renewed spikes in
cases;
Whereas the deadly COVID-19 outbreak in India is a global problem that requires
a coordinated global response;
Whereas in the spring of 2020, when the United States was in the midst of a
devastating spike in COVID-19 cases, India lifted its export ban on
certain therapeutics in response to a request by the United States
Government;
Whereas India's pharmaceutical industry is a vital part of the global solution
to the pandemic, especially for much of Asia, Africa, and Latin America,
and is the world's biggest producer of COVID vaccines having exported
66.36 million doses to 93 countries, including to United Nations
personnel and, accounting for over half of global vaccine manufacturing;
Whereas due to India's critical importance in global vaccine supply chains, an
increase in domestic vaccine demand as a result of the surge of COVID-19
cases within India is of global concern;
Whereas in response to the crisis in India, the Biden administration took quick
action to deliver urgently needed supplies to India, including oxygen
support, oxygen concentrators, personal protective equipment (PPE), raw
materials for vaccine, rapid diagnostic tests, and therapeutics, and is
a testament to the historic record of United States-India health
cooperation dating more than seven decades;
Whereas the United States private sector has worked to generously support relief
efforts in India including by working to deliver 1,000 ventilators and
25,000 oxygen concentrators to health care facilities across India;
Whereas many countries around the world have also sent medical assistance to
India to help the country defeat this devastating wave of the COVID-19
pandemic;
Whereas as the United States vaccine supply for the American people is secured,
it is important for the United States to continue to ramp up its
efforts, working with the private sector and all possible partners, to
expand vaccine manufacturing and distribution worldwide; and
Whereas United States support for India to help beat back this latest
coronavirus wave is in the United States national interest as the
pandemic will not end anywhere until it ends everywhere: Now, therefore,
be it
Resolved, That the House of Representatives--
(1) urges the Administration to facilitate private, in-kind medical
supply donations to India and deliver additional, urgently needed
medical supplies, including oxygen generator plants and a cryogenic
oxygen tanker and containers;
(2) urges the Administration to facilitate assistance as needed to
neighboring countries, including Nepal, that are facing the spread of
COVID-19 and working with partners around the world to address the
virus; and
(3) calls on the United States private sector and the Indian-
American community to continue their unprecedented and generous efforts
at procuring medical supplies for the Indian response during this time
of need, building upon contributions to date, standing with the people
of India as they collectively work to stem the spread of COVID-19.
Attest:
Clerk.